ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
BriaCell Therapeutics Corporation

BriaCell Therapeutics Corporation (BCTX)

1.53
-0.16
(-9.47%)
Closed June 04 4:00PM
1.53
0.00
(0.00%)
After Hours: 7:21PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
1.53
Bid
1.55
Ask
1.61
Volume
107,016
1.52 Day's Range 1.75
1.2699 52 Week Range 7.59
Market Cap
Previous Close
1.69
Open
1.70
Last Trade
1
@
1.58
Last Trade Time
Financial Volume
$ 175,223
VWAP
1.6374
Average Volume (3m)
123,271
Shares Outstanding
15,981,726
Dividend Yield
-
PE Ratio
-8.34
Earnings Per Share (EPS)
-1.27
Revenue
-
Net Profit
-20.3M

About BriaCell Therapeutics Corporation

BriaCell Therapeutics Corp is an immuno-oncology focused biotechnology company developing targeted and safe approaches for the management of cancer. BriaCell, in collaboration with Incyte Corp., is conducting a Phase I/IIa clinical trial of Bria-IMT, its lead candidate, in a Combination Study with I... BriaCell Therapeutics Corp is an immuno-oncology focused biotechnology company developing targeted and safe approaches for the management of cancer. BriaCell, in collaboration with Incyte Corp., is conducting a Phase I/IIa clinical trial of Bria-IMT, its lead candidate, in a Combination Study with Incyte drugs, INCMGA00012, and epacadostat, in advanced breast cancer. Additionally, it is developing Bria-OTS, off-the-shelf personalized immunotherapy, for advanced breast cancer. Bria-OTS immunotherapy treatments are personalized to match the patient without the need for personalized manufacturing and is designed to produce a potent and selective immune response against the cancer of each patient eliminating the time, expense and complex manufacturing logistics associated with immunotherapies. Show more

Sector
Aircraft
Industry
Business Services, Nec
Headquarters
Vancouver, British Columbia, Can
Founded
2009
BriaCell Therapeutics Corporation is listed in the Aircraft sector of the NASDAQ with ticker BCTX. The last closing price for BriaCell Therapeutics was $1.69. Over the last year, BriaCell Therapeutics shares have traded in a share price range of $ 1.2699 to $ 7.59.

BriaCell Therapeutics currently has 15,981,726 shares outstanding. The market capitalization of BriaCell Therapeutics is $169.41 million. BriaCell Therapeutics has a price to earnings ratio (PE ratio) of -8.34.

BCTX Latest News

BriaCell Presents Clinical Efficacy Data at ASCO 2024

BriaCell doubles Progression-Free-Survival (PFS) and Clinical Benefit Rate vs historical results in the literatureBria-IMTβ„’ PFS compares favorably to PFS of most recent treatment in 48% of...

BriaCell Initiates Patient Enrollment in First-in-Human Study of Bria-OTSβ„’ in Advanced Metastatic Breast Cancer

PHILADELPHIA and VANCOUVER, British Columbia, May 30, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (NASDAQ: BCTX, BCTXW) (TSX: BCT) (β€œBriaCell” or the β€œCompany”), a clinical-stage...

BriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTSβ„’ First in Human Study

Study to evaluate the effects of Bria-OTSβ„’ in combination with anti-PD-1 antibody tislelizumab, in advanced, late stage, heavily pretreated metastatic breast cancer. PHILADELPHIA and VANCOUVER...

BriaCell Doubles Progression-Free-Survival (PFS) and Reports Clinical Benefit Data at ASCO 2024

83% intracranial objective response rate (iORR) with Bria-IMTβ„’ in heavily pretreated advanced breast cancer patients with CNS metastasesMedian progression free survival (PFS) of 4.1 months in ADC...

BriaCell Therapeutics Announces Closing of $5.0 Million Registered Direct Offering

PHILADELPHIA and VANCOUVER, British Columbia, May 17, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (β€œBriaCell” or the β€œCompany”), a clinical-stage...

BriaCell Therapeutics Announces Pricing of $5.0 Million Registered Direct Offering

PHILADELPHIA and VANCOUVER, British Columbia, May 15, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (β€œBriaCell” or the β€œCompany”), a clinical-stage...

BriaCell Announces Oral and Poster Presentations at ASCO 2024

Oral presentation by Mayo Clinic Professor and Principal Investigator, Saranya Chumsri, MDTwo poster presentations include Drs. Hurvitz (Fred Hutchinson Cancer Center), Brufsky (UPMC), and...

BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+β„’ and Bria-PROS+β„’ Clinical Candidates for Breast and Prostate Cancer

Preclinical data shows that BriaCell’s Bria-OTS+β„’ and Bria-PROS+β„’ effectively induce an anti-cancer immune response via multiple mechanisms including naΓ―ve helper and killer T cells, dendritic...

BriaCell Showcases Data Demonstrating Unmatched Progression-Free Survival (PFS) and Clinical Efficacy in Antibody-Drug Conjugate (ADC) Resistant and Central Nervous System (CNS) Metastatic Breast Cancer at the 2024 AACR

PFS of 4.2 months in Phase 2 ADC resistant patients receiving Bria-IMTβ„’ pivotal Phase 3 formulation is twice that of controls in similar studies PFS results reinforced by larger number of prior...

BriaCell Receives and Executes Letter of Intent to Advance Clinical Development of Breast and Prostate Cancer Immunotherapies

Agreement with a leading cancer treatment group to advance the clinical development of Bria-OTS+ (breast cancer) and Bria-PROS+ (prostate cancer), BriaCell’s novel off-the-shelf personalized...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.085.517241379311.451.751.31781481431.58968385CS
4-0.75-32.89473684212.282.441.26992279131.5009498CS
12-1.42-48.13559322032.953.041.26991232711.92458366CS
26-3.96-72.1311475415.495.971.26991115003.0570829CS
52-4.55-74.83552631586.087.591.26991018864.31203846CS
156-4.76-75.67567567576.2912.471.26996644657.0792561CS
260-2.71-63.91509433964.2412.471.26998680526.58375301CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALBTAvalon GloboCare Corporation
$ 1.22
(313.56%)
159.29M
TOIIWOncology Institute Inc
$ 0.0315
(96.88%)
36.21k
HYWHywin Holdings Ltd
$ 0.6834
(94.65%)
11.07M
AFMDAffimed NV
$ 7.3028
(67.88%)
30.87M
GPCRStructure Therapeutics Inc
$ 52.9875
(54.93%)
11.8M
CAMPCalAmp Corp
$ 1.0185
(-61.85%)
2.38M
INBXInhibrx Biosciences Inc
$ 18.10
(-46.94%)
541.25k
VWEVintage Wine Estates Inc
$ 0.2077
(-41.82%)
2.75M
CNSPCNS Pharmaceuticals Inc
$ 0.1322
(-38.85%)
9.43M
PRTGPortage Biotech Inc
$ 0.3063
(-36.04%)
1.34M
CRKNCrown Electrokinetics Corporation
$ 0.1168
(16.80%)
298.46M
FFIEFaraday Future Intelligent Electric Inc
$ 0.6248
(7.10%)
228.85M
ALBTAvalon GloboCare Corporation
$ 1.22
(313.56%)
159.29M
MBOTMicrobot Medical Inc
$ 1.3714
(37.14%)
151.01M
SQQQProShares UltraPro Short QQQ
$ 9.93
(-0.90%)
134.02M

BCTX Discussion

View Posts
Monksdream Monksdream 1 month ago
BCTX. Under $3
πŸ‘οΈ0
QuicKtip QuicKtip 2 months ago
$BCTX Shows β€œStrong Anti-Cancer Activity of Bria-OTS+™ and Bria-PROS+™ Clinical Candidates for Breast and Prostate Cancer”

Press Release: https://bit.ly/4aJmAoc

$BCTX #CancerTreatment #Innovation
πŸ‘οΈ0
BigHeis BigHeis 2 months ago
Does anyone have information about the stock spinoff that occurred last year with this company? I have 600 shares of the spinoff security with 0 value and has remained that way since the spinoff. Thanks…
πŸ‘οΈ0
Monksdream Monksdream 2 months ago
BCTX new 52 lo
πŸ‘οΈ0
Monksdream Monksdream 3 months ago
BCTX new 52 lo
πŸ‘οΈ0
Monksdream Monksdream 3 months ago
BCTX 10Q due March 13
πŸ‘οΈ0
Monksdream Monksdream 4 months ago
BCTX new 52 week low
πŸ‘οΈ0
Monksdream Monksdream 4 months ago
BCTX new 52 week low
πŸ‘οΈ0
QuicKtip QuicKtip 6 months ago
$BCTX is thrilled to announce a new remarkable responder in our Phase 2 study of the Bria-IMT™ combination regimen. https://finance.yahoo.com/news/briacell-records-responder-remarkable-improvement-120000404.html
πŸ‘οΈ0
Sly1969 Sly1969 7 months ago
Good news today. I took a entry
πŸ‘οΈ0
Monksdream Monksdream 7 months ago
BCTX new 52 week low
πŸ‘οΈ0
benderostap4 benderostap4 11 months ago
2023 Anticipated Milestones, please?
πŸ‘οΈ0
smallcapvoice smallcapvoice 1 year ago
$BCTX $15 Price Target

Zacks Small-Cap Research just released a new report on BriaCell Therapeutics Corp. (Nasdaq: BCTX) with a $15 price target.

Read the full report here: https://scr.zacks.com/.../BCTX-Posters.../default.aspx

#Stocks #StocksToWatch #StockMarket
πŸ‘οΈ0
smallcapvoice smallcapvoice 1 year ago
BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) was featured in an article on Seeking Alpha
Discover more about this #BioTech company here: https://bit.ly/3DoEbUc
BriaCell Therapeutics: Fast-Tracking High-Potential Breast Cancer Immunotherapy
#Stocks #StocksToWatch
πŸ‘οΈ0
Onree Onree 1 year ago
Strange stock, but I've loved having it the past couple of years. I've mostly day traded, as there was a pretty good pattern last year, of early drops and late charges, and vice versa. I did end up getting stuck at around $10 so have been holding a lot at that level. Hopefully it runs again and I can keep chipping away at my mortgage because of the fancy researchers in Vancouver. Best of luck, all!
πŸ‘οΈ0
chenzo11 chenzo11 2 years ago
Yep, I'm still here. She's getting ready to burst! Low float/high short interest, Fast track approval and now up on big volume. Gonna get interesting!
πŸ‘οΈ0
Nickwvt Nickwvt 2 years ago
Under $4 by end of month
πŸ‘οΈ0
crudeoil24 crudeoil24 2 years ago
BriaCell Therapeutics Price Target Announced at $25.00/Share by HC Wainwright & Co.
πŸ‘οΈ0
crudeoil24 crudeoil24 2 years ago
BriaCell Reports Received FDA Fast Track Approval For Its Targeted Breast Cancer Immunotherapy

BCTX
πŸ‘οΈ0
chenzo11 chenzo11 2 years ago
I'm still here....wait til you see what happens this week

We will dance!
πŸ‘οΈ0
chenzo11 chenzo11 3 years ago
Closed above resistance of $10.50....We dance on Monday

Low float/high short interest. Setting up for big run
πŸ‘οΈ0
lucky__stock lucky__stock 3 years ago
$BCTX BriaCell is an immuno-oncology focused biotechnology company developing targeted and effective approaches for the management of cancer. More information is available at https://briacell.com/.

πŸ‘οΈ0
lucky__stock lucky__stock 3 years ago
$BCTX announces the addition of Suzanne Ostrand-Rosenberg, Ph.D. to its Scientific Advisory Board.

Dr. Ostrand-Rosenberg has more than 40 years of experience leading investigations focused on the immune system’s response to cancer. She is currently the Robert & Jane Meyerhoff Professor of Biochemistry, Emeritus, and Professor of Biological Sciences, Emeritus, University of Maryland Baltimore County, Baltimore, MD, and has been working with the University since 1977. She was also appointed as the Adjunct Professor of Pathology, Huntsman Cancer Institute (HCI), University of Utah, Salt Lake City, UT, in 2018. https://finance.yahoo.com/news/briacell-adds-pioneering-immunologist-cancer-130000276.html
πŸ‘οΈ0
lucky__stock lucky__stock 3 years ago
$BCTX has added Pioneering Immunologist and Cancer Immunotherapy Expert, Suzanne Ostrand-Rosenberg, Ph.D., to its Scientific Advisory Board!

Click here for a bio and to learn what she's bringing to the BriaCell team!

https://yhoo.it/3kbmmhX
πŸ‘οΈ0
EyalCap EyalCap 3 years ago
Easy Money for more $ZOM shares $BCTX thanks to @MrZackMorris for the tip in his Reddit community.. called this out last month on my Instagram big profits.. shorts are still all over this.. squeeze is to be prepared for.. get in profit big and get out .. October is #BreastCancerAwarenessMonth also load on $ZOM ?? it acquired Pulse Vet

$BCTX thanks to @MrZackMorris for the tip in his Reddit community.. called this out last month on my Instagram big profits.. shorts are all over this now.. squeeze is to be prepared for.. get in profit big and get out .. October is #BreastCancerAwarenessMonth also load on $ZOM πŸ’Ž pic.twitter.com/wJVS4lZydq— BL3 (@SellingStrikes) October 3, 2021
πŸ‘οΈ0
StockHighAlert- StockHighAlert- 3 years ago
(Nasdaq: BCTX, BCTXW) (TSX-V: BCT) CEO highlights key achievements of the company including recent collaboration with ImaginAb https://yhoo.it/3CDPzc7
πŸ‘οΈ0
StockHighAlert- StockHighAlert- 3 years ago
BriaCell Therapeutics Corp. (Nasdaq: $BCTX, $BCTXW) (TSX-V:BCT) News Alert https://yhoo.it/3gmjQ6A #stocks #medical #stockstowatch

πŸ‘οΈ0
Nebuchadnezzar Nebuchadnezzar 3 years ago
BCTX



https://schrts.co/gJajQPrD
πŸ‘οΈ0
ThurstonHowell ThurstonHowell 3 years ago
MarketsandMarkets 4th Annual Next Gen Immuno-Oncology Virtual Congress-US Edition: June 28-30, 2021
Dr. Williams will be speaking at the scientific conference at 11:30am ET on June 29, 2021.
The topic is β€œPersonalized, off-the-shelf cellular immunotherapy for cancer”.
A copy of the presentation will be posted here: https://briacell.com/novel-technology/scientific-publications/.
For additional information on the conference and the speaker, please visit:
https://events.marketsandmarkets.com/4th-annual-next-gen-immuno-oncology-virtual-congress-us-edition/speakers

Separately, BriaCell has recently appointed Miguel A. Lopez-Lago, Ph.D. as Senior Director, Research and Development. Since 2000, Dr. Lopez-Lago has been working as a cancer scientist at Memorial Sloan-Kettering Cancer Center, New York (MSKCC). Specifically, he has investigated various aspects of tumor biology, including the development of targeted therapies for Mesothelioma and the characterization of the biological mechanisms underlying cancer metastasis. More recently, Dr. Lopez-Lago has been interested in the study of the tumor immune-microenvironment and in the development of immunotherapies for thoracic cancers using chimeric antigen receptor (CAR) T cell technologies. Since 2013, Dr. Lopez-Lago has been working as Senior Research Scientist at MSKCC. Dr. Lopez-Lago received his Bachelor of Science in Bio-Sciences and his doctorate in Molecular Biology from Santiago of Compostela University, Spain.

About BriaCell Therapeutics Corp.

BriaCell is an immuno-oncology focused biotechnology company developing targeted and effective approaches for the management of cancer.

For additional information on BriaCell, please visit: https://briacell.com/.

πŸ‘οΈ0
ThurstonHowell ThurstonHowell 3 years ago
https://www.globenewswire.com/en/news-release/2021/05/11/2226965/0/en/BriaCell-to-Participate-at-Upcoming-Conferences-and-Appoints-Senior-R-D-Director.html
πŸ‘οΈ0
ThurstonHowell ThurstonHowell 3 years ago
https://www.globenewswire.com/news-release/2021/06/16/2248189/0/en/BriaCell-Therapeutics-Expands-Breast-Cancer-Platform-Technology-into-Prostate-Melanoma-and-Lung-Cancers.html
πŸ‘οΈ0
ThurstonHowell ThurstonHowell 3 years ago
https://finance.yahoo.com/news/briacell-reports-12-0-months-111200861.html
πŸ‘οΈ0
retireat40 retireat40 3 years ago
Terrible timing though. Absolutely killed any momentum.
πŸ‘οΈ0
HabibiFresh HabibiFresh 3 years ago
Yeah that wasn't bad news with private offering 27m institutional investment bullish for me

Seems that market didn't panic cos of the word "offering"

However this trading really weird lol halt > drop > halt into 7 smash > > drop > halt down
πŸ‘οΈ0
jwakstock jwakstock 3 years ago
Hopefully the squeeze alone will take it over $20.
πŸ‘οΈ0
timetomakemoney timetomakemoney 3 years ago
Yes, Nasdaq halted it again, Those MMS who naked shorted thare stock are screwed
πŸ‘οΈ0
cbrad10480 cbrad10480 3 years ago
My hunch the halt is because there are a bunch of FTD shares.
Thank You!

I like your hunch, let the squeeze begin!


cbrad
πŸ‘οΈ0
timetomakemoney timetomakemoney 3 years ago
What the Hell, there was a market for 3 minutes then they halted it again.
πŸ‘οΈ0
timetomakemoney timetomakemoney 3 years ago
PPS could go either way... My hunch the halt is because there are a bunch of FTD shares.
πŸ‘οΈ0
cbrad10480 cbrad10480 3 years ago
I've never seen a halt for news and the news is a private placement.

Does that mean that once resumed, the pps will gravitate toward the offering price
or will it cause the pps to go up?

Sorry for the newbie question, just trying to understand a little better.

cbrad
πŸ‘οΈ0
HabibiFresh HabibiFresh 3 years ago
We thinking buyout with this halt? Wouldn't halt this long for dilution
πŸ‘οΈ0
HabibiFresh HabibiFresh 3 years ago
Yeah real curious was about to happen
πŸ‘οΈ0
HabibiFresh HabibiFresh 3 years ago
100% resolution for eye-bulging tumors I love it
πŸ‘οΈ0
timetomakemoney timetomakemoney 3 years ago
Over an hour and BCTX is still halted.
πŸ‘οΈ0
HabibiFresh HabibiFresh 3 years ago
Yall seen a halt before big news before?
πŸ‘οΈ0
Penny chatter Penny chatter 3 years ago
Has to be more than that as it's still halted
πŸ‘οΈ0
retireat40 retireat40 3 years ago
Offering news out...$5.26 with exercise at $6.17 it appears.
πŸ‘οΈ0
timetomakemoney timetomakemoney 3 years ago
News Out! Public offering 5.2 million shares and warrants.
πŸ‘οΈ0
ANTADOG ANTADOG 3 years ago

Company: BriaCell Therapeutics Corp.

TSX-Venture Symbol: BCT

All Issues: Yes

Reason: At the Request of the Company Pending News

Halt Time (ET): 7:45 AM

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions
πŸ‘οΈ0
INFINITI INFINITI 3 years ago
Look again
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock